"Advanced materials and pharma are supposedly the first big application for quantum computing."
Lawrence Gasman, Founder and President of CIR
Following the publication of “Quantum Drug and Materials Design: Use Cases and Market Forecasts: 2026-2035,” Lawrence Gasman, Founder and President of CIR, commented:
Quantum computing is reshaping pharmaceutical research and advanced materials design. CIR’s new Report, “Quantum Drug and Materials Design: Use Cases and Market Forecasts: 2026-2035,” pinpoints current and future opportunities in this space. You can find more about this report and a link to get samples at https://www.cir-inc.com/product/quantum-chemistry-use-cases-and-market-forecasts/.
The report also analyzes companies that are already prominent in this field including IBM, Quantinuum, Google, Microsoft, IonQ, AstraZeneca, BASF, Pfizer, Airbus, Mercedes-Benz, and many others. In addition, the report contains a forecast of quantum computing in materials design and drug discovery with breakouts of the number of trials by size and expenditure levels. Advanced materials and pharma are supposedly the first big application for quantum computing. This report delivers detailed market analysis, technology assessment, partnership mapping, and ten-year forecasts. For questions about the report go to the report Web site or e-mail me at lawrence@cir-inc.com
Editor’s note: I contributed to this report.